Barbara Willekens

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Katrin Seeher, Nicoline Schiess, Emma Nichols et al. · The Lancet Neurology · 2024 · 1.7K citations · Full text

Medicine, Neurology, Neuroscience +17

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019

Dongze Wu, Yingzhao Jin, Yuhan Xing et al. · EClinicalMedicine · 2023 · 133 citations · Full text

Medicine, Health Sciences, Immunology +17

Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease

Carles Gaig, Yaroslau Compta, Anna Heidbreder et al. · Neurology · 2021 · 112 citations · Full text

Medicine, Neurology, Autoimmunity +11

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial

John Foley, Gilles Defer, Lana Zhovtis Ryerson et al. · The Lancet Neurology · 2022 · 110 citations

Medicine, Pharmacology, Pharmacotherapy +11